Pharmicell Co., Ltd. (005690.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

20.4x

EV/EBITDA

12.4x

Market Cap

KRW 622.84B

MomentumView details →

1D Return

−1.61%

YTD Return

−27.74%

RSI (14)

42.9

ValuationView details →

P/E (Fwd)

20.4x

EV/EBITDA

12.4x

Market Cap

KRW 622.84B

RSI (14)

42.9

MomentumView details →

1D Return

−1.61%

YTD Return

−27.74%

ProfitabilityView details →

Gross Margin

44.08%

Net Margin

34.26%

EBITDA Margin

34.57%

ROE (TTM)

32.49%

ROA (TTM)

25.29%

Asset Turnover

0.77x

GrowthView details →

Revenue YoY

+51.28%

EPS YoY

+124.74%

FCF YoY

+30.92%

Revenue CAGR 3Y

+23.75%

EPS CAGR 3Y

+69.58%

EBITDA YoY

+82.18%

EarningsView details →

EPS (Actual)

KRW 172.96

EPS Surprise

−18.80%

Beats (12Q)

0/12

Next Q EPS Est

KRW 236.00

Avg Surprise (4Q)

−9.40%

Rev Surprise

−7.41%

Capital & dividendView details →

Debt/Equity

0.18x

Current Ratio

7.15x

Quick Ratio

6.01x

Div Yield

0.48%

Div Rate

KRW 50.00

Div Growth 1Y

+150.00%

Financials snapshotView financials →

Revenue (TTM)

135.94B

Net Income (TTM)

46.57B

Op. CF (TTM)

41.02B

Next earningsNov 11, 2026 →

Latest newsMore news →

No recent news for 005690.KS.

Similar companies

Chabiotech Co.,Ltd.085660.KQ Medy-Tox Inc.086900.KQ Onconic Therapeutics476060.KQ GI Innovation, Inc.358570.KQ Green Cross Holdings Corporation005250.KS 百济神州688235.SH Find similar companies →

Latest newsMore news →

No recent news for 005690.KS.